Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-06-09Clinical Trial Update: Ranibizumab Treatment for Age-Related Macular Degeneretion [NA]
This document is a clinical trial update about using ranibizumab to treat age-related macular degeneration, with the study status listed as …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration [Phase 3]
This is a Phase 3 clinical trial completion update for ranibizumab (rhuFab V2) in patients with minimally classic or occult subfoveal neovas…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Sirolimus for Advanced Age-Related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluated sirolimus for advanced age-related macular degeneration and geographic atrophy; results were posted aft…
-
FDA approval · 2014-05-06FDA Approved: VISUDYNE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for VISUDYNE (verteporfin for injection) filed by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS research · 2014-04-30Clinical Trial Update: Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration [Phase 2, Phase 3]
Clinical trial update for MacuCLEAR MC-1101 in non-exudative age-related macular degeneration. The study is a Phase II/III trial and the cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-04-28Clinical Trial Update: Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration [Phase 2, Phase 3]
A Phase 2/Phase 3 efficacy and safety trial of MC-1101 for nonexudative age-related macular degeneration has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration [Phase 1]
The update reports the completion of a Phase 1 safety study of a topical treatment for dry age-related macular degeneration. The sponsor is …
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival [NA]
A completed trial compared topical versus subconjunctival anesthesia for intravitreal injections in AMD, CRVO, and DME. Results were posted …
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: The MAP Study: Fluocinolone Acetonide (FA)/Medidur (TM) for Age Related Macular Degeneration (AMD) Pilot [Phase 2]
This entry notes the completion of a Phase 2 pilot trial evaluating fluocinolone acetonide (Medidur) for age-related macular degeneration, w…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab [Phase 4]
Phase 4 clinical trial assessing indocyanine green angiography changes in choroidal neovascularization during ranibizumab treatment for exud…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 extension study of ranibizumab (rhuFab V2) for neovascular age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration [Phase 3]
A Phase 3 clinical trial comparing rhuFab V2 to Verteporfin photodynamic therapy for subfoveal neovascular age-related macular degeneration …
-
CLINICAL_TRIALS research · 2014-03-18Clinical Trial Update: Monocentric Retrospective Observational Study on Patients With Macular Degeneration
This is a monocentric retrospective observational clinical trial update focusing on patients with exudative age-related macular degeneration…
-
CLINICAL_TRIALS trial_result · 2014-03-13Clinical Trial Update: Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration. [Phase 2]
Phase 2 safety study on retinal transplantation for dry age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-03-11Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy [Phase 2]
Phase 2 trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of ACU-4429 in geographic atrophy due to dry age-re…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) [Phase 3]
Phase 3 trial evaluating ranibizumab for choroidal neovascularization secondary to age-related macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-12Clinical Trial Update: Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration [Phase 4]
This Phase 4 pilot trial compares ranibizumab with and without ketorolac eye drops for exudative age-related macular degeneration. The study…
-
CLINICAL_TRIALS research · 2014-01-20Clinical Trial Update: Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)
A completed clinical trial update examining the association between macular pigment optical density and Complement Factor H genetic variants…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) [Phase 2]
A multicenter Phase 2 proof-of-concept trial of intravitreal AL-78898A in geographic atrophy due to age-related macular degeneration was ter…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Genetic Load and Phenotype in Aggressive AMD
A completed clinical trial update examining genetic load and phenotype in aggressive age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Antioxidant Systems and Age-Related Macular Degeneration
This entry reports the completion of a clinical trial evaluating antioxidant systems in age-related macular degeneration.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Preventing Depression in Patients With Macular Degeneration [Phase 3]
Phase 3 trial evaluating prevention of depression in patients with macular degeneration has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-03Clinical Trial Update: A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration [Phase 2]
Phase 2 trial update evaluating E10030 (Anti-PDGF pegylated aptamer) plus Lucentis for neovascular age-related macular degeneration has comp…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Age-Related Eye Disease Study 2 (AREDS2) [Phase 3]
AREDS2 is a Phase 3 trial that has completed. It evaluated antioxidant and mineral supplementation for age-related macular degeneration and …
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration [Phase 1, Phase 2]
This document reports a Phase 1/2 safety study examining autologous bone marrow-derived stem cells as a treatment for age-related macular de…